Clinical Trials · NCT04979130
Comparing Semaglutide Versus Placebo on Intestinal Barrier Function in Type 2 Diabetes Mellitus (SIB)
- Phase
- Phase 4
- Recruitment status
- Completed
- Sponsor
- University of Colorado, Denver
- Enrollment
- 69
- Start date
- Jan 2022
- Locations
- 1 site, United States
- Primary endpoint
- Differences in lactulose mannitol ratio (LMR) test as a measure of intestinal permeability between treatment groups